Skip to main content
Chordia Therapeutics,Inc logo

Chordia Therapeutics,Inc — Investor Relations & Filings

Ticker · 190A ISIN · JP3283730004 T Professional, scientific and technical activities
Open in API
Filings indexed 18 across all filing types
Latest filing 2024-06-06 Share Issue/Capital Cha…
Country JP Japan
Listing T 190A

About Chordia Therapeutics,Inc

https://www.chordiatherapeutics.com/en.…

Chordia Therapeutics, Inc. is a clinical-stage biotechnology company specializing in the research and development of novel cancer therapies. The company focuses on discovering and developing first-in-class, small-molecule drugs that target RNA deregulation, a key driver in various cancers. Its mission is to create life-changing treatments for patients by advancing a pipeline of innovative drug candidates from preclinical research through clinical trials.

Recent filings

Filing Released Lang Actions
訂正有価証券届出書（新規公開時）
Share Issue/Capital Change Classification · 98% confidence The document text is titled "訂正有価証券届出書（新規公開）" which translates to "Amended Securities Registration Statement (Initial Public Offering)". It details the terms of a public offering (募集要項) and an over-allotment sale (売出要項) of shares, including the offering price (発行価格), underwriting price (引受価額), capital increase details, and use of proceeds. This structure and content are characteristic of a registration statement filed in connection with an Initial Public Offering (IPO) in Japan, which corresponds to the US SEC's Form S-1 or similar initial registration documents for securities offerings. Among the provided codes, the closest match for a comprehensive filing detailing the terms of a new security issuance (IPO/public offering) is not explicitly listed as a standard SEC form (like 10-K or DEF 14A). However, the document is clearly a formal filing related to the issuance and sale of securities, which falls under the broader category of capital/financing activities or a primary regulatory filing. Given the context of a 'Securities Registration Statement' for a 'New Public Offering' (新規公開), this document is fundamentally about raising capital through the issuance of shares. The most appropriate category among the choices that covers major financing/capital structure changes is 'Capital/Financing Update' (CAP). While it is a formal registration statement, 'CAP' captures the core economic purpose better than the general 'RNS' or the specific report types listed.
2024-06-06 Japanese
訂正有価証券届出書（新規公開時）
Capital/Financing Update Classification · 98% confidence The document is titled "訂正有価証券届出書（新規公開）" which translates to "Amended Securities Registration Statement (Initial Public Offering)". It is submitted to the Kanto Local Finance Bureau ("関東財務局長"). The content details the offering of new shares ("新規発行株式"), the method of offering ("募集の方法"), the terms of the offering ("募集の条件"), the underwriters ("株式の引受け"), and the use of proceeds from the new issue ("新規発行による手取金の使途"). This structure and terminology are characteristic of a prospectus or registration statement filed in Japan for an Initial Public Offering (IPO). Among the provided codes, 'CAP' (Capital/Financing Update) is the closest fit as it deals directly with the issuance of new shares for fundraising, although a more specific code for an IPO registration statement might be preferred if available. Given the options, this document is fundamentally about a capital raising event (issuance of shares for public offering). Since it is a comprehensive filing detailing the offering terms, it is more substantial than a simple 'RPA' or 'RNS'. 'CAP' covers financing activities, which an IPO is. However, in the context of US-centric filings where '10-K' is the annual report, Japanese filings like this (which are essentially prospectuses for IPOs) often fall under a broader category if a specific IPO code isn't present. Since the core activity is raising capital through share issuance, 'CAP' is the most appropriate choice among the provided list, as it details the structure and terms of the share issuance.
2024-05-29 Japanese
有価証券届出書（新規公開時）
Capital/Financing Update Classification · 98% confidence The document is titled "有価証券届出書（新規公開）" which translates to "Securities Registration Statement (Initial Public Offering)". This document details the terms of a public offering of new shares (募集) and potential over-allotment sales (売出し), including the offering method (ブックビルディング方式 - book-building method), underwriting details (株式の引受け), and the intended use of the proceeds (手取金の使途). This content is characteristic of a registration statement filed prior to an IPO in Japan, which corresponds to the regulatory filing category for initial public offerings or major capital structure changes related to new securities issuance. Given the options, this is a filing related to capital/financing activities, specifically an IPO registration. While it is a regulatory filing, the specific nature points strongly towards 'Capital/Financing Update' (CAP) as it is the core subject matter, detailing the issuance terms. However, in the context of mandatory SEC/FSA filings, a comprehensive registration statement like this (which is the Japanese equivalent of a US S-1 or F-1) is a primary regulatory disclosure. Since 'CAP' covers fundraising/financing activities, and this document is the formal registration for that activity, 'CAP' is highly relevant. If a more general regulatory filing code were needed, 'RNS' might apply, but 'CAP' is more specific to the content. Given the structure and purpose (registering a new share issue), 'CAP' is the best fit among the provided definitions, although it is fundamentally a regulatory filing. Revisiting the definitions: 'CAP' is for 'Updates on company fundraising, financing activities, or capital structure changes.' This document is the formal registration for a fundraising activity (IPO). Therefore, 'CAP' is the most appropriate classification based on the document's primary function described in the text.
2024-05-10 Japanese

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.